PRIMARY STUDY
The value of Rowatinex in the treatment of ureterolithiasis
Key Findings: A higher success rate was noted in the Rowatinex group when compared to the placebo group, although this was not statistically significant.
Type of Study: Double Blind Clinical Trial
Study Result: Positive
Research Location(s): Israel
Year of Pub: 1987
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: Borneol, Eucalyptol, Pinene
Route of Administration: Oral (Ingestion)
Citation: Mukamel E, et al. The value of Rowatinex in the treatment of ureterolithiasis. J Urol (Paris). 1987; 93:31-3.
Authors: Mukamel E, Engelstein D, Simon D, Servadio C
